acitretin has been researched along with Kaposi Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedier, H; Julien, LA; Lin, J; Routy, JP | 1 |
| Corbeil, J; Looney, DJ; Rapaport, E; Richman, DD | 1 |
2 other study(ies) available for acitretin and Kaposi Sarcoma
| Article | Year |
|---|---|
Concurrent development of HIV-negative Kaposi's sarcoma and mycosis fungoides in an elderly Inuit from Canada.
Topics: Acitretin; Administration, Cutaneous; Aged, 80 and over; Anti-Inflammatory Agents; Herpesvirus 8, Human; Humans; Hydrocortisone; Immunocompromised Host; Immunosenescence; Inuit; Male; Mycosis Fungoides; Neoplasms, Multiple Primary; Sarcoma, Kaposi; Skin Neoplasms; Ultraviolet Therapy | 2021 |
Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells.
Topics: Acitretin; Benzoates; Cell Division; Fibroblast Growth Factor 2; Humans; Interleukin-6; Isotretinoin; Male; Receptors, Fibroblast Growth Factor; Receptors, Interleukin; Receptors, Interleukin-6; Retinoids; RNA, Messenger; Sarcoma, Kaposi; Tretinoin; Tumor Cells, Cultured | 1994 |